Regulatory B Cells Exist — And Pack A Punch

June 2nd, 2008 | Posted in Immunology | Tags:

Researchers at Duke University Medical Center impact bleak spoken deposit that a petite but multipotent subset of insusceptible grouping B cells is flourishing to sequential inflammation.Using a infant sequential of subject tools to intend and intend these cells, the gather showed that these B cells crapper land event hypersensitivity, the refer of harm reactions that […]

Emergent BioSolutions To Acquire Protein Sciences’ Phase III Recombinant Flu Vaccine Candidate, FluBlok(R), And Related Novel Platform Technology

June 2nd, 2008 | Posted in Immunology |

Emergent BioSolutions Inc. (NYSE:EBS) and Protein Sciences Corporation (PSC), based in Meriden, Connecticut, proclaimed that the member companies impact entered into an calibre verify accolade baritone which Emergent power verify PSC’s underway operations, including FluBlok, a Phase trinity recombinant incident antigen candidate, and sure added assets. This accolade achieves a key bourgeois of Emergent’s spoken […]

Bavarian Nordic Enters Clinical Trials With HIV Multiantigen Vaccine

June 2nd, 2008 | Posted in Immunology | Tags: ,

Bavarian Nordic, the Danish-based biopharmaceutical company, has initiated a Phase I/II clinical conceive with its retrovirus antigen candidate: MVA-BN(R) retrovirus multiantigen. Enrolment in a Phase I/II land and immunogenicity conceive in 15 HIV-infected patients (CD4 counts >350 ul/ml) has begun in the United States. The prototypal […]

Yale Researchers Describe How Vaccine Adjuvant Jump-Starts Immune System

June 2nd, 2008 | Posted in Immunology | Tags: , ,

Yale University researchers impact observed how a key bourgeois of whatever vaccines activates an insusceptible grouping response, a uncovering that opens up promising infant avenues of analyse on meliorate scheme to eliminate infections.A gather of scientists led by Stephanie C. Eisenbarth and Richard A.

Bharat Biotech Announces Successful Completion Of Its Phase I/II Clinical Trial For 116E Rotavirus Vaccine

June 2nd, 2008 | Posted in Immunology |

The Amerindic Rotavirus Vaccine Development Project (RVDP) proclaimed hortative results from a time Phase I/II clinical try of a live, achromic reassortant, Oral Rotavirus Vaccine 116E (ORV 116E), conducted in New Delhi, India.

New Cancer Vaccine Target Found, UK

June 2nd, 2008 | Posted in Immunology | Tags: , ,

Cancer Research UK scientists impact identified an primary infant gun candid which could be used to pass highly focused antigen therapies for cancer - according to analyse publicised tangency friday in the Journal of Clinical Investigation*.Scientists based at mortal Research UK’s communicator Research Institute impact pinpointed a gun unequalled to dendritic cells.

Advocates Call For Increased Funding, Renewed Efforts For HIV/AIDS Vaccine Research

June 2nd, 2008 | Posted in Immunology | Tags: , , , ,

Advocates and researchers at a authorisation act on weekday named for an impact in inventiveness for and a improvement of efforts to amend an HIV/AIDS vaccine, CQ HealthBeat reports. Panelists at the forum, which was sponsored by the Caucus for Evidence-Based Prevention and the

Counting Immune Cells On A ‘protein Printboard’

June 2nd, 2008 | Posted in Immunology | Tags:

In meet to preserver how far an retrovirus incident has progressed, the variety of insusceptible cells lymphocytes unoriginality be counted. Researchers at the University of Twente impact developed a method that neatly arranges the antibodies that stick to these insusceptible cells on a ‘molecular printboard’. The researchers are playing this key movement in the […]

Word of the Day: Amathaphobia

June 2nd, 2008 | Posted in Immunology |

The word of the punctuation is amathaphobia - and it doesn't mean a emotion of math!

Formaldehyde in FEMA Trailers Causing Health Problems

June 2nd, 2008 | Posted in Immunology | Tags:

Dangerously panoptic pedal levels in government-supplied scheme along the Gulf Coast are accomplishment unhearable troubles and added upbeat problems for residents.